Cellular targets of kinase inhibitors are identified by mass spectrometric analysis of binding to “kinobeads.”
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Bantscheff, M. et al. Nat. Biotechnol. 25, 1035–1044 (2007).
Brehmer, D. et al. Cancer Res. 65, 379–382 (2005).
Godl, K. et al. Cancer Res. 65, 6919–6926 (2005).
Graves, P.R. et al. Mol. Pharmacol. 62, 1364–1372 (2002).
Haystead, C.M., Gregory, P., Sturgill, T.W. & Haystead, T.A. Eur. J. Biochem. 214, 459–467 (1993).
Ross, P.L. et al. Mol. Cell. Proteomics 3, 1154–1169 (2004).
Druker, B.J. et al. Nat. Med. 2, 561–566 (1996).
Shah, N.P. et al. Science 305, 399–401 (2004).
Golas, J.M. et al. Cancer Res. 63, 375–381 (2003).
Avivi-Green, C., Singal, M. & Vogel, W.F. Am. J. Respir. Crit. Care Med. 174, 420–427 (2006).
Daniels, C.E. et al. J. Clin. Invest. 114, 1308–1316 (2004).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
White, F. On the iTRAQ of kinase inhibitors. Nat Biotechnol 25, 994–996 (2007). https://doi.org/10.1038/nbt0907-994
Issue Date:
DOI: https://doi.org/10.1038/nbt0907-994